Curis Inc. | Key People and Executives
Ali Fattaey
President, Chief Executive Officer & Director
Lori Anne Kunkel
Director
Martyn D. Greenacre
Chairman
Kenneth I. Kaitin
Independent Director
Marc Rubin
Independent Director
Ali Fattaey
President, Chief Executive Officer & Director
James E. Dentzer
COO, CFO, CAO, Secretary & Treasurer
Robert E. Martell
Head-Research & Development
Lori Anne Kunkel
Director
Martyn D. Greenacre
Chairman
Kenneth I. Kaitin
Independent Director
Marc Rubin
Independent Director
| Address |
4 Maguire Road
Lexington Massachusetts 02421
United States
|
|
Employees
|
- |
| Website |
http://www.curis.com |
| Updated |
07/08/2019 |
| Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. |
